0.094 USD
-0.01 (-11.32%)
0.095 USD
+0 (+1.06%)
We assign a fundamental rating of 2 out of 10 to DMTK. DMTK was compared to 525 industry peers in the Biotechnology industry. DMTK may be in some trouble as it scores bad on both profitability and health. DMTK is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year DMTK has reported negative net income.
- In the past year DMTK has reported a negative cash flow from operations.
- In the past 5 years DMTK reported 4 times negative net income.
- DMTK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -87.04%, DMTK is doing worse than 73.69% of the companies in the same industry.
- The Return On Equity of DMTK (-224.09%) is worse than 71.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -87.04% | ||
| ROE | -224.09% | ||
| ROIC | N/A |
ROA(3y)-57.34%
ROA(5y)-43.66%
ROE(3y)-99.56%
ROE(5y)-68.72%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of DMTK (8.51%) is better than 74.22% of its industry peers.
- DMTK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- DMTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
- DMTK has more shares outstanding than it did 1 year ago.
- Compared to 1 year ago, DMTK has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -8.44, we must say that DMTK is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of DMTK (-8.44) is worse than 73.69% of its industry peers.
- DMTK has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.00, DMTK perfoms like the industry average, outperforming 49.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.44 |
ROIC/WACCN/A
WACC10.37%
2.3 Liquidity
- A Current Ratio of 3.53 indicates that DMTK has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 3.53, DMTK is doing worse than 61.85% of the companies in the same industry.
- DMTK has a Quick Ratio of 3.46. This indicates that DMTK is financially healthy and has no problem in meeting its short term obligations.
- DMTK has a Quick ratio of 3.46. This is in the lower half of the industry: DMTK underperforms 61.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.53 | ||
| Quick Ratio | 3.46 |
3. Growth
3.1 Past
- DMTK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.77%, which is quite impressive.
- The Revenue has grown by 9.80% in the past year. This is quite good.
- The Revenue has been growing by 37.45% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)30.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.14%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y37.45%
Revenue growth 5YN/A
Sales Q2Q%10.58%
3.2 Future
- The Earnings Per Share is expected to grow by 15.08% on average over the next years. This is quite good.
- Based on estimates for the next years, DMTK will show a small growth in Revenue. The Revenue will grow by 6.40% on average per year.
EPS Next Y35.19%
EPS Next 2Y15.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.8%
Revenue Next 2Y6.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- DMTK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DMTK. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as DMTK's earnings are expected to grow with 15.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.08%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- DMTK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DERMTECH INC / DMTK FAQ
What is the ChartMill fundamental rating of DERMTECH INC (DMTK) stock?
ChartMill assigns a fundamental rating of 2 / 10 to DMTK.
What is the valuation status for DMTK stock?
ChartMill assigns a valuation rating of 0 / 10 to DERMTECH INC (DMTK). This can be considered as Overvalued.
What is the profitability of DMTK stock?
DERMTECH INC (DMTK) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for DMTK stock?
The Earnings per Share (EPS) of DERMTECH INC (DMTK) is expected to grow by 35.19% in the next year.